
3 курс / Фармакология / Плацебо и терапия
.pdf
. .
2000
55.6
72
. .
72 . « ». — .: -
« », 2000. — 224 . ISBN 5-8114-0254-6
,
, « »,
: , , , , , ,
, , , , .
, -
,
, , , .
, , -
« », .
, ,
^ , , .
55.6
. . , . .
© « », 2000 © . . , 2000 © « »,
, 2000
|
|
|
|
|
|
|
....................................... |
|
7 |
|
|
|
|
|
|
|
|
|
||
....................... |
|
8 |
|
|
|
|
- ................ |
11 |
|
|
|
||
, |
|
|
|
|||
. . |
15 |
|
||||
... |
23 |
|||||
........................... |
|
23 |
|
|
|
|
.......................... |
|
23 |
|
|
|
|
........................... |
|
23 |
|
|
|
|
.................... |
27 |
|
|
|
|
|
......................... |
|
|
30 |
|
|
|
...................................... |
30 |
|
|
|
|
|
.......... |
|
35 |
|
|
||
.............................. |
|
40 |
|
|
|
|
.................... |
40 |
|
|
|
|
|
|
..................... |
42 |
|
|
|
|
....................................... |
|
45 |
|
|
|
|
|
.......................... |
|
46 |
|
|
|
.............................. |
|
48 |
|
|
|
|
............................... |
|
49 |
|
|
|
|
..................... |
|
52 |
|
|
||
( . DOUBLE BUND METHOD) |
.... 58 |
|||||
|
. . 61 |
|
||||
................................ |
|
65 |
|
|
|
|
......................... |
|
|
65 |
|
|
|
................. |
|
|
69 |
|
||
|
|
|
||||
............................ |
71 |
|
|
|
|
|
|
|
|
||||
...................... |
|
71 |
|
|
|
|
.................. |
|
72 |
|
|||
............. |
74 |
|
||||
|
|
|
||||
........................... |
|
79 |
|
|
|
|
|
|
|
|
|
||
...................... |
|
79 |
|
|
|
|
..................... |
80 |
|
|
|
|
|
.............. |
|
80 |
|
|
||
? |
...... 81 |
|
||||
? . . |
83 |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5* |
|
|
|
|
|
|
.................. |
83 |
|
|
|
|
|
.................. |
|
85 |
|
|||
.......... |
|
88 |
|
|
||
................... |
90 |
|
|
|
PRESSI ( HERSON )
» ......... |
96 |
|
|
||||
|
|
|
|
|
|
|
|
« » ............ |
|
97 |
|
|
|
||
.......... |
|
99 |
|
|
|||
» |
|
................... |
101 |
|
|
|
|
................... |
|
|
101 |
|
|||
.......................... |
|
103 |
|
|
|
|
|
................................. |
|
104 |
|
|
|
|
|
................................. |
|
104 |
|
|
|
|
|
............... |
105 |
|
|
|
|||
............. |
|
106 |
|
|
|||
.............. |
|
108 |
|
|
|
||
......109 |
|
||||||
............................ |
|
109 |
|
|
|
|
|
........................... |
|
110 |
|
|
|
|
|
............................... |
111 |
|
|
|
|
|
|
( ).................. |
112 |
|
|
|
|||
( )........ |
|
113 |
|
|
|||
............................... |
|
116 |
|
|
|
|
|
................................ |
|
117 |
|
|
|
|
|
................................ |
|
124 |
|
|
|
|
|
......................... |
|
|
|
125 |
|
|
|
|
.................. |
|
125 |
|
|
|
|
, |
|
|
|
|
|
||
? .................. |
|
128 |
|
|
|
|
|
|
|
|
|
|
|||
?.................... |
|
128 |
|
|
|
|
|
............................. |
|
142 |
|
|
|
||
................... |
|
|
144 |
|
|||
, |
|
||||||
?............................. |
|
145 |
|
|
|
|
|
. . . |
148 |
||||||
|
|
|
|||||
(VS. )........ |
148 |
|
|||||
? ............... |
|
151 |
|
|
|||
.............................. |
|
153 |
|
|
|
||
|
........................ |
|
153 |
|
|
||
? |
............. |
155 |
|
||||
................. |
|
|
|
158 |
|
||
« » ................. |
|
161 |
|
|
|
||
|
|
................... |
164 |
|
|
|
|
....................... |
|
171 |
|
|
|
|
|
|
|
|
|
|
|
||
................. |
|
173 |
|
|
|
|
|
.... |
177 |
|
|||||
.... |
180 |
|
|||||
(compliance)......................... |
|
181 |
|
|
|
|
|
................................. |
|
199 |
|
|
|
|
|
SUMMARY ..................................... |
|
200 |
|
|
|
|
|
|
|
........................ |
|
201 |
|
|
|
................................... |
|
205 |
|
|
|
|
|
..................................... |
|
223 |
|
|
|
|
|
|
|
|
|
|
|
|
|
CONTENTS |
|
|
|
|
|
|
|
PREFACE ........................................ |
|
7 |
|
|
|
|
|
Placebo and psychology of therapy |
|
|
|
|
|
||
in scientific literature........................ |
|
8 |
|
|
|
|
|
Unity of pharmacoand psychotherapy............... |
11 |
|
||
Historic roots of religious beliefs, prejudices and |
|
|||
fantasies about the action of remedies and treatments ... 15 |
|
|||
PSYCHOLOGICAL COMPONENTS OF PHARMACOTHERAPY ... 23 |
||||
VERBAL FACTORS................................ |
|
23 |
|
|
Reputation of a medication ...................... |
|
23 |
|
|
Name of a medication .......................... |
|
23 |
|
|
Text of the leafsheet........................... |
|
27 |
|
|
NONVERBAL FACTORS .................................... |
|
|
30 |
|
Color and mind .............................. |
|
30 |
|
|
Some shades of psychology of color |
................. |
35 |
|
|
Taste of the pill .............................. |
|
40 |
|
|
Size of the pill ............................... |
|
40 |
|
|
Psychology of the low price of medications............ |
42 |
|
||
PLACEBO ....................................... |
|
45 |
|
|
DEFINITION OF PLACEBO ........................... |
|
|
46 |
|
HISTORY OF PLACEBO ............................. |
|
|
48 |
|
FORMS OF PLACEBO............................... |
|
49 |
|
|
ETHICS OF USE OF PLACEBO......................... |
|
52 |
|
|
DOUBLE BLIND METHOD............................ |
|
|
58 |
|
Double blind method in testing efficacy of new medicines |
. . 61 |
|||
PLACEBO EFFECT ................................ |
|
65 |
|
|
FORMS OF PLACEBO EFFECT ......................... |
|
65 |
|
|
POSITIVE PLACEBO EFFECT.............................. |
|
|
69 |
|
Positive placebo effect |
|
|
|
|
as a diagnostic method ...................... |
|
71 |
|
|
Positive placebo effect in prediction |
|
|
|
|
of efficacy of a new drug..................... |
|
71 |
|
|
NEGATIVE PLACEBO EFFECT......................... |
|
72 |
|
|
RATE OF PLACEBO EFFECT |
.......................... |
|
74 |
|
CONCERNING THE METHODS OF STUDYING OF PLACEBO EFFECT . . 79 |
||||
Role of information in placebo effect................ |
|
79 |
|
|
Pharmacodynamics of placebo..................... |
|
80 |
|
|
Latency of placebo effect........................ |
|
80 |
|
|
How long placebo effect can last? .................. |
|
81 |
|
|
Is placebo effect constant in the same person?.......... |
83 |
|
||
6 |
|
|
|
|
|
|
|
|
|
I |
|
|
|
|
I1 |
|
|
|
|
Instability of placebo effect ...................... |
|
83 |
|
|
PLACEBO EFFECT IN HEALTHY PERSONS.................... |
85 |
|||
in car drivers................................ |
88 |
|
|
|
in athlets .................................. |
90 |
|
|
|
«Placebo effect» in laboratory animals............... |
96 |
|
||
Addiction to placebo and |
|
|
|
|
«placebo withdrawal effect»................... |
|
97 |
|
|
Family and parents placebo effect .................. |
|
99 |
|
|
«Inderect placebo effect» ....................... |
|
101 |
|
|
MECHANISMS OF PLACEBO EFFECT.................... |
101 |
|||
motivation of treatment........................ |
|
103 |
|
|
expectation ................................ |
104 |
|
|
|
suggestion................................. |
104 |
|
|
|
conditioned reflexes .......................... |
|
105 |
|
|
stable pathologic state (according to N. P. Bekhtereva) |
. . . 106 activation of opioidergic system |
|||
.................. 108 |
|
|
|
|
PLACEBO EFFCT IN SOME DISEASES....................... |
109 |
PRESSI ( HERSON )
Insomnias ................................. |
|
109 |
|
|
|
Pain syndromes ............................. |
110 |
|
|
||
Angina ................................... |
|
Ill |
|
|
|
Anxiety................................... |
112 |
|
|
|
|
Panic disorders (panic attacks)......... |
:......... |
113 |
|
|
|
Schizophrenia .............................. |
116 |
|
|
|
|
Alcoholism |
................................ |
117 |
|
|
|
Epilepsy .................................. |
|
124 |
|
|
|
PLACEBO REACTIVITY ............................ |
|
125 |
|
|
|
Prediction of placebo reactivity................... |
|
125 |
|
|
|
Which symptoms are more and which |
|
|
|
||
are less susceptible to placebo?................ |
|
128 |
|
|
|
Is there any correlation between placebo reactivity |
|
|
|||
and prefernce of colors? .................... |
128 |
|
|
||
PLACEBO CONTROL............................... |
|
142 |
|
|
|
CONCERNING THE METHOD OF PLACEBO CONTROL ......... |
144 |
||||
ARE HOMEOPATHIC MEDICINES SUPERIOR TO PLACEBO?....... |
145 |
||||
PLACEBO CONTROL OF EFFICACY OF ACUPUNCTURE .......... |
148 |
||||
CONTROL (EVIDENCE) OF EFFICACY OF PSYCHOTHERAPY |
......148 |
||||
Side effects of psychotherapy ?................... |
|
151 |
|
|
|
PLACEBO THERAPY .............................. |
|
153 |
|
|
|
ETHICS OF PLACEBO THERAPY ...................... |
153 |
|
|||
WHO AND WHEN COULD BE TREATED WITH PLACEBO? ...... |
155 |
||||
EFFICACY OF PLACEBO THERAPY..................... |
158 |
|
|||
«Patient-doctor» communication.................. |
|
161 |
|
|
|
Relation of patient to doctor..................... |
|
164 |
|
|
|
Relation to medication........................ |
171 |
|
|
||
Relation of doctor pharmacotherapy |
|
|
|
||
and concrete medication.................... |
173 |
|
|
||
Psychotropic drugs from a viewpoint of a patient ...... |
177 |
|
|||
Psychotropic drugs amd medical staff.............. |
180 |
|
|
||
Compliance |
................................ |
181 |
|
|
|
CONCLUSION .................................. |
|
199 |
|
|
|
SUMMARY |
..................................... |
200 |
|
|
|
SUBJECT INDEX................................. |
|
201 |
|
|
|
LITERATURE ................................... |
|
205 |
|
|
|
ABOUT THE AUTHOR ............................. |
|
223 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
. |
|
|
|
|
|
|
, |
|
, |
, , ,
, . ,
, , (
, , , , , ),
, ,
. , ,
, ,
,
.
,
, ( ).
— « » « » (
. placeo — ). « »,
( . ., 1989),
8
.
, , , ,
, , ., ,
. ( . ., 1989) ,
, . ,
« » , . . ( .: . ., 1989) , « ,
, . , ».
, ( , ,
.)
.
, ,
. ,
, « » -
, ,
. ,
.
, .
, , , ,
. I
9
«Placebo», «Placebo-controlled», «Placebo effect», «Placebo therapy», «Psychological», «Personality»
«Current Contents», 29 000 ,
. «Index Medicus»
.
Medline, 3600 ,
. -
, 30 .
( , 1980; Shapiro ., 1978; Klerman G. L., 1986; Rickels ., 1986; Schoemaker P. G. W., 1995; Montgomery G., Kirsch I., 1996; De Deyn P. P. et al., 1996; Silvis S. E., 1996; Straus J. L., Ammon von S., 1996; Wall M., Wheeler S., 1996),
, ( . . ., ., 1997; Bok S., 1974; Illhardt F. J., 1988), (Samson E., 1986) -
. ,
(Orr R. D., 1996; Piercy M. A. et al., 1996; Schweizer E., Rickels ., 1997; Straus J. L., Ammon von C. S., 1996), (Bienenfeld L. et al., 1996),
(Zaijcek G., 1997) .
(Heeg M. J. et al., 1997).
(Brown W. ., 1998)
— «Scientific American».
, , Brody . (1980), White L., Tursky ., Schwartz G. E. (1985), Hippius H. et al. (1986), 80- .
, . 10
,
30 .
( . ., . ., 1976; -
. . ., 1994), (
. ., 1989),
PRESSI ( HERSON )
. ., 1978), ( . ., 1976),
( . ., . ., 1982;
. ., 1990 ; . ., . ., 1997).
.
«
» ( . ., 1965), «
» ( . ., . ., 1982), «
( . ., . ., 1985).
. . «
» « » (
. ., 1966). , , . .
« » (1991).
, , ,
, , ,
, ,
, , .
3-
( , , 4-10 1961 ). « »
-
11
, , «
» (Rinkel M. (ed.)> 1963),
. : «
» (Lasagna L.), « . „ "
" » (Di Mascio A., Rinkel M.), «
(variables) » (Malitz S.), « -
. » (Feldman P. E.).
, «
», .
.
(Klerman G. L., Di Mascio A., Rinkel M., Green-blatt M., 1959; Di Mascio ., Barrett J., 1965; Henin-ger G., Di Mascio A., Klerman G. L., 1965).
-
,
,
.
- , ,
Herman van Praag (1979),
( ). — « —
» — .
,
— « » « » —
« * (Stier S., 1997). 12
¥.
- , ,
. ,
, , ,
,
.
, . . (1980),
. ,
— ,
.
. . , ,
,
.
, ,
, ,
».
.
,
. , ,
, ,
13
. -
(Karasu ., 1982; Hyland J., 1991).
( )
(
. ., 1997). , , -
.
, . . ,
.
-
, .
, ,
, ,
,
, ( . ., 1985).
.
(Rosental D., Frank J. D., 1956; Wilkins W., 1984).
(Gliedman L. H., Nash E. H., Imber S. D. et al., 1958).
. . , ,
, .
, , , -
,
14
, «
!».
, - ,
, ,
. ,
,
(Strauss W. H., Klieser E., 1997).
, . Hafner (1987),
(to cope) ,
. — — .
( )
,
. »
PRESSI ( HERSON )
(Sperry L., 1995), , ,
.
« » « »
«
. — . .) », 16-21
1997 («The Synthesis between Psychophar-macology and Psychotherapy» WPA Thematic Conference; Jerusalem, Israel, Nov. 16-21, 1997).
: « , ( , « », « ». — ..) », « - », «
- », « -
», « -
-
15
», « — ».
, ,
,
(British Medical Journal, 1984), ,
. ,
, , , ,
( ) ,
», « », « ».
,
, ,
, , ( , ,
).
« »
. ,
, . ,
, . , , , ,
.
, , , : «
?» . : « ».
: « . ». , :
. !», i\
, , , :
? ? ( )?
( , , )?
? , , , , ,
». , ." .
, . .
(Shapiro A., 1978) .
, « » .
, ,
» (Shapiro A., 1978).
.
XIX ,
, ,
, , -
, « ,
» (Shapiro A., 1978).
? , ,
, (
— . ) , , ,
. . ...
, , , , , ,
). . .
. ,
.
? , ,
17
, ! . ,
. , -
,
, .
? , . , — .
. , ,
) , ,
.
, , ,
, . ,
, ,
,
, — , .
,
,
, .
.
, ,
.
.
, ,
,
,
18
I
« » ( ) .
, , :
, .
,
, . ,
, ,
, « ,
, ,
». . #
, .
. ,
, , ,
. , (
), , « » :
—, — ; : — ,
— , — . «
PRESSI ( HERSON )